2-chloro-1-propanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID Source	ID
PubMed CID	6566
MeSH ID	M0150776

Synonyms (41)

Synonym
1-propanol, 2-chloro-, (s)-
2-chloro-propan-1-ol
1-hydroxy-2-chloropropane
nsc-122672
2-chloropropanol
2-chloro-1-propanol
nsc122672
2-chloropropyl alcohol
propylenechlorohydrin
.beta.-chloropropyl alcohol
78-89-7
wln: q1yg1
1-propanol, 2-chloro-
nsc 122672
ccris 875
einecs 201-154-3
hsdb 5223
2-chloropropan-1-ol
un2611
beta-chloropropyl alcohol
FT-0652650
FT-0657974
A4232
AKOS006228269
unii-w3398732c7
w3398732c7 ,
propylene chlorohydrin [un2611] [poison]
1-hydroxy-2-chloropropane [hsdb]
propylene chlorohydrin [mi]
.beta.-propylene chlorohydrin
(r)-2-chloro-1-propanol
DTXSID5052541
J-640389
un 2611
W-109278
propylenchlorhydrin
Q15461615
SY240135
SB44668
SB44669
EN300-91182

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	1 (12.50)	18.7374
1990's	3 (37.50)	18.2507
2000's	1 (12.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	2 (25.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	41.52 (24.57)
Research Supply Index	2.30 (2.92)
Research Growth Index	5.15 (4.65)
Search Engine Demand Index	53.09 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (41.52)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (11.11%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (88.89%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
ethylene chlorohydrin Ethylene Chlorohydrin: Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration.. chloroethanol : An organochlorine compound that is ethanol substituted by at least one chloro group.	2.39	2	chloroethanol	xenobiotic metabolite
glycerol Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.	2.6	1	alditol; triol	algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent
1-propanol 1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.. propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.	2.4	2	propan-1-ols; short-chain primary fatty alcohol	metabolite; protic solvent
4-aminopyridine [no description available]	1.97	1	aminopyridine; aromatic amine	avicide; orphan drug; potassium channel blocker
ethylene oxide Ethylene Oxide: A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794). oxirane : A saturated organic heteromonocyclic parent that is a three-membered heterocycle of two carbon atoms and one oxygen atom.	1.97	1	gas molecular entity; oxacycle; saturated organic heteromonocyclic parent	allergen; mouse metabolite; mutagen
propylene propylene: structure	2.6	1	alkene; gas molecular entity	refrigerant; xenobiotic
3-chloro-1-propanol 3-chloro-1-propanol: an inhibitor of triosephosphate isomerase and glyceraldehyde 3-phosphate dehydrogenase	2.04	1
chlorine Chlorine: An element with atomic symbol Cl, atomic number 17, and atomic weight 35, and member of the halogen family.	2.04	1	diatomic chlorine; gas molecular entity	bleaching agent
1-chloro-2-propanol 1-chloro-2-propanol: RN given refers to cpd without isomeric designation. 1-chloropropan-2-ol : A secondary alcohol that is isopropanol in which one of the methyl hydrogen atoms is substituted by chlorine.	3.51	2	organochlorine compound; secondary alcohol
n,o-bis(trimethylsilyl)trifluoroacetamide [no description available]	2.15	1

Condition	Relationship Strength	Studies
Hematologic Malignancies [description not available]	1.99	1
Diseases, Occupational [description not available]	2.39	2
Cancer of Pancreas [description not available]	2.39	2
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).	2.39	2
Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.	1.99	1
Leucocythaemia [description not available]	1.97	1
Benign Neoplasms [description not available]	1.97	1
Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	1.97	1
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	1.97	1

chemdatabank.com